Masonic Cancer Center, University Of Minnesota

This study tested whether adding a drug called VIC-1911 to standard medications can prevent graft-versus-host disease (GVHD) and cancer relapse after a stem cell transplant. Sixteen adults with blood cancers like leukemia or lymphoma took part. The goal was to find the best dose …

This early-phase study tested a new drug called HCW9218 in 18 people with advanced solid tumors that had not responded to at least two prior treatments. The drug works by activating immune cells and blocking signals that help tumors grow. The main goal was to find a safe dose and…

This study tested whether two special drinks can help the body remove environmental toxins and cancer-causing chemicals. 300 healthy adults, including smokers and non-smokers, participated. Researchers measured toxin byproducts in urine to see if the drinks boosted detoxification…

This study gave a special radioactive drug (131I-MIBG) to 15 patients with advanced neuroblastoma or pheochromocytoma who had run out of standard treatments. The goal was to see if it could shrink tumors and ease symptoms, while tracking side effects. Patients received different …

This study looked at whether physical therapy can improve arm, shoulder, and hand problems that some people develop after breast cancer surgery. It involved 135 women and men who had surgery to remove breast cancer and at least one lymph node. The goal was to see if therapy helps…

This study tested whether it's possible to run a smoking study entirely through telehealth visits. 64 adult smokers were asked to use cigarettes with either minimal or moderate filter ventilation. Researchers measured how much they smoked, their nicotine levels, and other health …

This study tested if the amount of sugar in cigarette tobacco changes how appealing or addictive the cigarettes are. Thirty adult smokers tried cigarettes with different sugar levels and answered questions about their experience. The goal was to see if lower-sugar cigarettes migh…